EBIT: As of FY2026, the actual value is USD 241.9 M.

Operational Metrics

For the second quarter of 2026, Pediatrix Medical Group, Inc. confirmed its payor mix remained stable and unchanged compared to recent historical trends and internal expectations . The company has not experienced unfavorable payor mix shifts reported elsewhere in the healthcare sector, nor has it seen material changes in other net revenue-related trends compared to recent historical periods .

Outlook / Guidance

Pediatrix Medical Group, Inc. reaffirms its previously reported full year 2026 outlook for Adjusted EBITDA, anticipating it will be in a range of $280 million to $300 million . The projected financial components for the year ended December 31, 2026, include Net income ranging from $152,100 thousand to $166,700 thousand, Interest expense of $33,500 thousand, Income tax provision between $56,300 thousand and $61,700 thousand, Depreciation and amortization expense of $24,800 thousand, and Transformational and restructuring related expenses of $13,300 thousand .